| Enrollment of racial minorities in clinical trials: old problem assumes new urgency in the age of immunotherapy B Nazha, M Mishra, R Pentz, TK Owonikoko American Society of Clinical Oncology Educational Book 39, 3-10, 2019 | 211 | 2019 |
| Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? B Nazha, E Moussaly, M Zaarour, C Weerasinghe, B Azab World journal of gastrointestinal surgery 7 (12), 370, 2015 | 203 | 2015 |
| Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy B Nazha, C Inal, TK Owonikoko Frontiers in Oncology 10, 1000, 2020 | 189 | 2020 |
| Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer B Nazha, JCH Yang, TK Owonikoko Future Oncology 17 (8), 965-977, 2021 | 57 | 2021 |
| High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells M Boya, T Ozkaya-Ahmadov, BE Swain, CH Chu, N Asmare, ... Nature communications 13 (1), 3385, 2022 | 39 | 2022 |
| Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study S Pakkala, K Higgins, Z Chen, G Sica, C Steuer, C Zhang, G Zhang, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 39 | 2020 |
| Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation: Meta-Analysis of Phase III Trials B Nazha, B Pandya, J Cohen, M Zhang, RD Lopes, DA Garcia, ... Circulation 138 (14), 1402-1411, 2018 | 37 | 2018 |
| Students’ perceptions of peer-organized extra-curricular research course during medical school: a qualitative study B Nazha, RH Salloum, AC Fahed, M Nabulsi PloS one 10 (3), e0119375, 2015 | 33 | 2015 |
| Immune-related adverse events as clinical biomarkers in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, ... The Oncologist 26 (10), e1742-e1750, 2021 | 25 | 2021 |
| Primary non-Hodgkin’s lymphoma of the spine: a case report and literature review E Moussaly, B Nazha, M Zaarour, JP Atallah World journal of oncology 6 (5), 459, 2015 | 25 | 2015 |
| Body composition variables as radiographic biomarkers of clinical outcomes in metastatic renal cell carcinoma patients receiving immune checkpoint inhibitors DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, ... Frontiers in Oncology 11, 707050, 2021 | 24 | 2021 |
| Advances in knowledge and management of immune-related adverse events in cancer immunotherapy TA Olsen, TZ Zhuang, S Caulfield, DJ Martini, JT Brown, BC Carthon, ... Frontiers in Endocrinology 13, 779915, 2022 | 19 | 2022 |
| Body composition as an independent predictive and prognostic biomarker in advanced urothelial carcinoma patients treated with immune checkpoint inhibitors DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, ... The Oncologist 26 (12), 1017-1025, 2021 | 19 | 2021 |
| Student support for reproductive health education in middle schools: findings from Lebanon F Mouhanna, J DeJong, R Afifi, K Asmar, B Nazha, H Zurayk Sex Education 17 (2), 195-208, 2017 | 16 | 2017 |
| Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer B Nazha, S Goyal, Z Chen, A Engelhart, JW Carlisle, TJ Beardslee, H Gill, ... Cancer 126 (23), 5040-5049, 2020 | 15 | 2020 |
| Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, ... Journal for ImmunoTherapy of Cancer 9 (7), 2021 | 14 | 2021 |
| Metastatic clear-cell renal cell carcinoma in the era of immune checkpoint inhibitors: therapies and ongoing trials TZ Zhuang, K Case, TA Olsen, JT Brown, BC Carthon, O Kucuk, ... Cancers 14 (12), 2867, 2022 | 11 | 2022 |
| Clinical outcomes and racial disparities in metastatic hormone-sensitive prostate cancer in the era of novel treatment options KER Smith, JT Brown, L Wan, Y Liu, G Russler, L Yantorni, S Caulfield, ... The Oncologist 26 (11), 956-964, 2021 | 11 | 2021 |
| Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer M Zaarour, C Weerasinghe, B Nazha, S Hassan, JP Atallah Expert Review of Anticancer Therapy 15 (11), 1327-1336, 2015 | 11 | 2015 |
| Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers B Nazha, T Zhuang, S Wu, JT Brown, D Magee, BC Carthon, O Kucuk, ... Cancer 129 (24), 3884-3893, 2023 | 10 | 2023 |
Mehmet Asim BilenWinship Cancer Institute of Emory UniversityVerified email at emory.edu
